Skip to content

Efficacy and mechanism of individualized transcranial magnetic stimulation based on resting state functional magnetic resonance in the treatment of depression

Efficacy and mechanism of individualized transcranial magnetic stimulation based on resting state functional magnetic resonance in the treatment of depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054793
Enrollment
Unknown
Registered
2021-12-27
Start date
2021-12-31
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Group 1:Individualized TMS
Group 2:TMS with the traditional 5-cm rule

Sponsors

Affiliated Brain Hospital of Guangzhou Medical University; Tianjin Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. Meet the DSM-5 diagnostic criteria for depression, and the diagnosis is confirmed by the MINI-International Neuropsychiatric Interview (M.I.N.I.); 3. The current medication is an SSRI antidepressant, and there has been no adjustment in the past two weeks; 4. The score of 17 items of Hamilton Depression Scale (Hamilton Depression Scale-17, HAMD-17) should not be less than 17 points.

Exclusion criteria

Exclusion criteria: 1. Diagnosed as bipolar disorder or depression with psychotic symptoms; 2. Combined with other mental illness; 3. Currently taking antipsychotic medication; 4. Accompanied by serious organic brain diseases, such as epilepsy, stroke, encephalitis, brain trauma, etc., or serious physical diseases such as malignant tumors, acute heart failure, multiple organ failure, etc.; 5. A history of alcohol or drug dependence; 6. Women who are pregnant or breastfeeding; 7. There are contraindications to magnetic resonance scanning such as metal implants and claustrophobia.

Design outcomes

Primary

MeasureTime frame
Scale scores;

Countries

China

Contacts

Public ContactZhang Bin

Tianjin Anding Hospital

zhang.bin845@foxmail.com+86 189 8893 2815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 1, 2026